All Publications & Resources

The Cost of Inaction on Rheumatic Heart Disease: Technical Report 
Cannon J, Katzenellenbogen JM, Wyber R, Nedkoff L, Greenland M, Cunneen R, Bond-Smith D, de Klerk N, Sanfiliippo FM, Carapetis JR

Public health and economic perspectives on acute rheumatic fever and rheumatic heart disease
Jeffrey Cannon, Dawn C Bessarab, Rosemary Wyber and Judith M Katzenellenbogen
Med J Aust 2019; 211 (6): . || doi: 10.5694/mja2.50318

Rapid Review: Acute Rheumatic Fever and Rheumatic Heart Disease in Australia
An analysis of the 2019 Australian Institute of Health and Welfare (AIHW) report into rates of acute rheumatic fever and rheumatic heart disease in Australia.

A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies
Robert M Hand, Sam Salman, Nelly Newall, Julie Vine, Madhu Page-Sharp, Asha C Bowen, Katherine Gray, Amy Baker, Joseph Kado, John Joseph, Julie Marsh, James Ramsay, Dianne Sika-Paotonu, Kevin T Batty, Laurens Manning, Jonathan Carapetis
Journal of Antimicrobial Chemotherapy, dkz076, 15 April 2019

Community-based participatory action research on rheumatic heart disease in an Australian Aboriginal homeland: Evaluation of the ‘On track watch’ project
Emma Haynes, MinitjaMarawilic, Brendan Makungun Marikac, Alice G. Mitchell,  Jodi Phillips Dawn Bessarab, Roz Walker, Jeff Cooke, Anna P. Ralph
Evaluation and Program Planning, 2019 June 74:38-53

Pre-Budget Submission 2019-2020
Resourcing the beginning of the end of rheumatic heart disease in Australia

The Cost of Inaction on Rheumatic Heart Disease
R. Wyber, J. Cannon, and J. Katzenellenbogen.

How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease
Jessica Langloh de Dassel Nick de Klerk Jonathan Rhys Carapetis Anna P. Ralph
Journal of the American Heart Association. 2018;7:e010223

Time to tackle rheumatic heart disease: Data needed to drive global policy dialogues.
Abouzeid M, Wyber R, La Vincente S, Sliwa K, Zühlke L, Mayosi B, Carapetis J.

"That Heart Sickness": Young Aboriginal People's Understanding of Rheumatic Fever.
Mitchell AG, Belton S, Johnston V, Gondarra W, Ralph AP.
Med Anthropol. 2018 Aug 1:1-14.

Rheumatic heart disease in pregnancy: strategies and lessons learnt implementing a population-based study in Australia.
Vaughan G, Tune K, Peek MJ, Jackson Pulver L, Remenyi B, Belton S, Sullivan EA.
Int Health. 2018 Nov 1;10(6):480-489.

An economic case for a vaccine to prevent group A streptococcus skin infections.
Cannon JW, Jack S, Wu Y, Zhang J, Baker MG, Geelhoed E, Fraser J, Carapetis JR.
Vaccine. 2018 Nov 12;36(46):6968-6978.

Ascertaining infectious disease burden through primary care clinic attendance among young Aboriginal children living in four remote communities in Western Australia.
Hendrickx D, Bowen AC, Marsh JA, Carapetis JR, Walker R.
PLoS One. 2018 Sep 17;13(9):e0203684

Rheumatic heart disease in pregnancy: How can health services adapt to the needs of Indigenous women? A qualitative study.
Belton S, Kruske S, Jackson Pulver L, Sherwood J, Tune K, Carapetis J, Vaughan G, Peek M, McLintock C, Sullivan E.
Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):425-431

Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study.
Cannon J, Dyer J, Carapetis J, Manning L.
Clin Microbiol Infect. 2018 Oct;24(10):1084-1088.

Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study.
Cannon J, Rajakaruna G, Dyer J, Carapetis J, Manning L.
Clin Microbiol Infect. 2018 Oct;24(10):1089-1094. 

Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8.
Campbell PT, Frost H, Smeesters PR, Kado J, Good MF, Batzloff M, Geard N, McVernon J, Steer A. Vaccine. 2018 Nov 29;36(50):7618-7624.

The fall and rise of Group A Streptococcus diseases.
Barnett TC, Bowen AC, Carapetis JR.
Epidemiol Infect. 2018 Aug 15:1-6.

Qualitative Evaluation of a Complex Intervention to Improve Rheumatic Heart Disease Secondary Prophylaxis
Clancy Read; Alison G. Mitchell; Jessica L. de Dassel; Clair Scrine; David Hendrickx; Ross S. Bailie; Vanessa Johnston; Graeme P. Maguire; Rosalie Schultz; Jonathan R. Carapetis; Anna P. Ralph.

Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High‐Burden Setting: Outcome of a Stepped‐Wedge, Community, Randomized Trial
Anna P. Ralph; Jessica L. de Dassel; Adrienne Kirby; Clancy Read; Alison G. Mitchell; Graeme P. Maguire; Bart J. Currie; Ross S. Bailie; Jonathan R. Carapetis

[Briefing note] Secondary prophylaxis delivery – lessons learnt to date
An overview of existing literature on priorities for improving secondary prophylaxis delivery

Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease
Montagnat, O.D., Webster, G.R., Bullita, J. et al. 
Drug Deliv. and Transl. Res. (2018).

Rheumatic heart disease: infectious disease origin, chronic care approach
Katzenellenbogen JM, Ralph AP, Wyber R, Carapetis JR.
BMC Health Services Research. 2017;17(1). 

The rationale for action to end new cases of rheumatic heart disease in Australia
Wyber R, Katzenellenbogen J, Pearson G, Gannon M.
Med J Aust 2017; 207 (8): 322-323. doi: 10.5694/mja17.00246

Rheumatic heart disease across the Western Pacific: not just a Pacific Island problem
Abouzeid M, Katzenellenbogen J, Wyber R, et al
Heart Asia 2017; 9: e010948. doi: 10.1136/heartasia-2017-010948

Rheumatic heart disease severity, progression and outcomes: a multi-state model.
Cannon J, Roberts K, Milne C, Carapetis JR.
J Am Heart Assoc. 2017 Mar 2;6(3). pii: e003498. doi: 10.1161/JAHA.116.003498.

Echocardiographic screening for rheumatic heart disease in Indigenous Australian children: a cost-utility analysis.
Roberts K, Cannon J, Atkinson D, Brown A, Maguire G, Remenyi B, Wheaton G, Geelhoed E, Carapetis JR.
JAm Heart Assoc. 2017 Mar 2;6(3). pii: e004515. doi: 10.1161/JAHA.116.004515.

Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data.
de Dassel JL, Fittock MT, Wilks SC, Poole JE, Carapetis JR, Ralph AP.
PLoS One. 2017 May 31;12(5):e0178264. doi: 10.1371/journal.pone.0178264. eCollection 2017.

Global, regional, and national burden of rheumatic heart disease, 1990-2015.
Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT, Mayosi BM, Mensah GA, Nascimento BR, Ribeiro ALP, Sable CA, Steer AC, Naghavi M, Mokdad AH, Murray CJL, Vos T, Carapetis JR, Roth GA.
N Engl J Med. 2017 Aug 24;377(8):713-722. doi: 10.1056/NEJMoa1603693.

Clinical outcomes for young people with screening-detected and clinically-diagnosed rheumatic heart disease in Fiji.
Engelman D, Mataika RL, Ah Kee M, Donath S, Parks T, Colquhoun SM, Carapetis JR, Kado JH, Steer AC.
Int J Cardiol. 2017 Aug 1;240:422-427. doi: 10.1016/j.ijcard.2017.04.004. Epub 2017 Apr 6

Outcomes after mitral valve surgery for rheumatic heart disease.
Russell EA, Walsh WF, Reid CM, Tran L, Brown A, Bennetts JA, Baker RA, Tam R, Maguire GP
Heart Asia 2017;9(2):e010916

Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence.
Engelman D, Ah Kee M, Mataika RL, Kado JH, Colquhoun SM, Tulloch J, Steer AC.
Trans R Soc Trop Med Hyg. 2017 Apr 1;111(4):154-162. doi: 10.1093/trstmh/trx035.

Crusted scabies in northern and central Australia - now is the time for eradication.
Quilty S, Kaye TS, Currie BJ
Med J Aust. 2017 Feb 6;206(2):96.

Prescribing for people with acute rheumatic fever.
Ralph AP, Noonan S, Boardman C, Halkon C, Currie BJ.
Aust Prescr. 2017 Apr;40(2):70-75. doi: 10.18773/austprescr.2017.011. Epub 2017 Apr 3.

Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations.
Zühlke LJ, Beaton A, Engel ME, Hugo-Hamman CT, Karthikeyan G, Katzenellenbogen JM, Ntusi N, Ralph AP, Saxena A, Smeesters PR, Watkins D, Zilla P, Carapetis J.
Curr Treat Options Cardiovasc Med. 2017 Feb;19(2):15. doi: 10.1007/s11936-017-0513-y.

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients.
Russell EA, Walsh WF, Tran L, Tam R, Reid CM, Brown A, Bennetts JS, Baker RA, Maguire GP
Int J Cardiol. 2017 Jan 15;227:100-105. doi: 10.1016/j.ijcard.2016.11.070. Epub 2016 Nov 9

Outcome following valve surgery in Australia: development of an enhanced database module.
Russell EA, Reid CM, Walsh WF, Brown A, Maguire GP
BMC Health Serv Res. 2017; 17: 43.

The epidemiology of scabies and impetigo in relation to demographic and residential characteristics: baseline findings from the skin health intervention Fiji trial.
Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Ritova R, Andrews R, Kaldor JM, Steer AC
Am J Trop Med Hyg. 2017 Jul 17. doi: 10.4269/ajtmh.16-0753. [Epub ahead of print]

Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania.
Parks T, Mirabel MM, Kado J, Auckland K, Nowak J, Rautanen A, Mentzer AJ, Marijon E, Jouven X, Perman ML, Cua T, Kauwe JK, Allen JB, Taylor H, Robson KJ, Deane CM, Steer AC, Hill AVS; Pacific Islands Rheumatic Heart Disease Genetics Network.
Nat Commun. 2017 May 11;8:14946. doi: 10.1038/ncomms14946.

Clinical development strategy for a candidate group A streptococcal vaccine.
Schödel F, Moreland NJ, Wittes JT, Mulholland K, Frazer I, Steer AC, Fraser JD, Carapetis J.
Vaccine. 2017 Apr 11;35(16):2007-2014. doi: 10.1016/j.vaccine.2017.02.060. Epub 2017 Mar 16.

The WHF roadmap for reducing CV morbidity and mortality through prevention and control of RHD.
Palafox B, Mocumbi AO, Kumar RK, Ali SKM, Kennedy E, Haileamlak A, Watkins D, Petricca K, Wyber R, Timeon P, Mwangi J.
Glob Heart. 2017 Mar;12(1):47-62. doi: 10.1016/j.gheart.2016.12.001. Epub 2017 Mar 20.

A comprehensive needs assessment tool for planning RHD control programs in limited resource settings.
Zühlke LJ, Watkins DA, Perkins S, Wyber R, Mwangi J, Markbreiter J, Moloi HS, Engel ME, Shato T, Hermanus T, DeVries J, Read C.
Glob Heart. 2017 Mar;12(1):25-31. doi: 10.1016/j.gheart.2016.10.028. Epub 2017 Feb 27.